Pfizer News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

12.04.21	Myovant, Pfizer Initiate SERENE Study Evaluating Contraceptive Efficacy Of Relugolix (RTTNews)
07.04.21	Pfizer Says Priority Review Period Extended For NDA For Abrocitinib- Quick Facts (RTTNews)
07.04.21	Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis (Businesswire)
06.04.21	Pfizer Suspends Covid-19 Vaccines Shipment To Israel Over Payment Issues: Report (RTTNews)
02.04.21	Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Review Oncology Business on April 9, 2021 (Businesswire)
01.04.21	Pfizer : High Vaccine Efficacy Observed Through Up To 6-months After Second Dose Of COVID-19 Vaccine (RTTNews)
01.04.21	Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study (Businesswire)
31.03.21	Pfizer/BioNTech's COVID-19 Vaccine Shows 100% Efficacy In Late-stage Trial In Adolescents (RTTNews)
31.03.21	Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents (Businesswire)
29.03.21	CDC: Pfizer And Moderna COVID Vaccines Found 90% Effective In "Real-World Conditions (RTTNews)
27.03.21	Biotech Stocks Facing FDA Decision In April 2021 (RTTNews)
25.03.21	Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain (Businesswire)
25.03.21	Pfizer : Real-World Evidence Supports Effectiveness Of Ibrance Combination Therapy In Breast Cancer (RTTNews)
25.03.21	Real-World Evidence Supports Effectiveness of First-line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer (Businesswire)
24.03.21	Myovant & Pfizer: Long-term Study Supports Potential Benefit Of Relugolix Combination Therapy (RTTNews)
23.03.21	Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2 (Businesswire)
23.03.21	Pfizer Invites Public to View and Listen to Webcast of Pfizer May 4 Conference Call with Analysts (Businesswire)
23.03.21	AZN's COVID-19 Jab Shows 79% Efficacy, ZEAL Wins FDA Approval, AdComm To Review Osteoarthritis Drug (RTTNews)
17.03.21	WuXi Biologics To Buy Biologics DS & DP Manufacturing Facilities From Pfizer China (RTTNews)
11.03.21	Johnson & Johnson' Single-dose COVID-19 Vaccine Recommended For Use In EU (RTTNews)
11.03.21	Real-world Data Shows Effectiveness Of At Least 97% For Pfizer-BioNTech COVID-19 Vaccine (RTTNews)
11.03.21	Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared (Businesswire)
09.03.21	Genome Signs Deal With Merck KGaA And Pfizer For Immuno-oncology Microbiome Study (RTTNews)
09.03.21	Roche : FDA Oks Ventana Assay To Identify Lung Cancer Patients Eligible For Treatment With LORBRENA (RTTNews)
08.03.21	Valneva, Pfizer Initiate Phase 2 Study For Lyme Disease Vaccine Candidate (RTTNews)
04.03.21	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
04.03.21	KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent (RTTNews)
04.03.21	FDA Expands Approval Of Pfizer's Lorbrena As Treatment For ALK-Positive Metastatic Lung Cancer (RTTNews)
04.03.21	U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer (Businesswire)
27.02.21	FDA Says 'rapidly Works Toward' Emergency Use Approval Of J&J's Single-shot COVID-19 Vaccine (RTTNews)
26.02.21	Pfizer Says EMA Accepted Marketing Authorization Application For Growth Hormone Somatrogon (RTTNews)
26.02.21	EMA Accepts Pfizer's MAA For 20-valent Pneumococcal Conjugate Vaccine Candidate For Adults (RTTNews)
26.02.21	European Medicines Agency Accepts Pfizer’s Marketing Authorization Application for Its Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age or Older (Businesswire)
26.02.21	EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency (Businesswire)
25.02.21	Pfizer, BioNTech Initiate Study To Evaluate COVID-19 Booster And New Vaccine Variants (RTTNews)
25.02.21	Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants (Businesswire)
23.02.21	U.S. FDA Accepts for Priority Review Pfizer’s Application for TicoVac™ (Tick-borne Encephalitis Vaccine) (Businesswire)
23.02.21	Pfizer, Moderna To Increase Covid Vaccine Supply (RTTNews)
22.02.21	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
19.02.21	Pfizer Submits Data Showing COVID-19 Vacccine's Stability At Standard Freeze Temperature (RTTNews)
19.02.21	FLXN On Track, IMNM Discovers Antibodies To Fight S. African Variant, RIGL In Deal With LLY (RTTNews)
18.02.21	NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch (RTTNews)
17.02.21	Pfizer Initiates Phase 2 Trial Of BCMA-CD3 Bispecific Antibody Elranatamab In Multiple Myeloma (RTTNews)
17.02.21	Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma (Businesswire)
17.02.21	Pfizer, BioNTech Agree To Supply Additional 200 Mln Doses Of COVID-19 Vaccine To EU member States (RTTNews)
17.02.21	Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY® (Businesswire)
15.02.21	Pfizer Vaccine Approved In Japan; Israeli Study Shows 94% Effective (RTTNews)
12.02.21	U.S. FDA Approves PANZYGA® for the Treatment of Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Businesswire)
10.02.21	BioNTech: COVID-19 Vaccines Manufactured At Marburg Site Scheduled For Distribution In April (RTTNews)
08.02.21	Roche : FDA Grants Breakthrough Device Designation To Elecsys GDF-15 Assay (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

16:02		Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel hätten Anleger an einem Johnson Johnson-Investment von vor 3 Jahren verloren
24.12.24		Börse New York: Dow Jones zeigt sich zum Handelsende fester
24.12.24		Zuversicht in New York: Dow Jones am Dienstagnachmittag mit Gewinnen
24.12.24		AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück
24.12.24		Freundlicher Handel: Letztendlich Gewinne im Euro STOXX 50
24.12.24		Dienstagshandel in London: Letztendlich Gewinne im FTSE 100
24.12.24		Börse Europa in Grün: STOXX 50 steigt schlussendlich